Third-generation progestogen type influences hemostatic changes caused by oral contraceptives in Brazilian women

Contraception

Volumn 64, Issue 6, 2001, Pages 353-356

  Ferreira, A C P ^a   Montes, M B A ^a   Franceschini, S A ^b   Toloi, M R T ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF RIBEIRÃO PRETO   (Brazil)

Author keywords

Desogestrel; Ethinyl estradiol; Gestodene; Hemostasis; Oral contraceptives; Thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; DESOGESTREL; ETHINYLESTRADIOL; FIBRIN; GESTAGEN; GESTODENE; ORAL CONTRACEPTIVE AGENT; PLASMINOGEN; PROTEIN C; PROTEIN S; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ARTICLE; BLOOD CLOTTING; BRAZIL; CONTRACEPTION; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FIBRINOLYSIS; HEMOSTASIS; HUMAN; NORMAL HUMAN; PROTEIN BLOOD LEVEL; THROMBOSIS;

ADULT; BLOOD COAGULATION; BRAZIL; COAGULATION PROTEIN DISORDERS; CONTRACEPTIVES, ORAL; CONTRACEPTIVES, ORAL, SYNTHETIC; DESOGESTREL; ETHNIC GROUPS; FEMALE; FIBRINOLYSIS; HEMOSTASIS; HUMANS; NORPREGNENES; PROGESTERONE CONGENERS;

EID: 0035709167     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(01)00274-8     Document Type: Article

References (18)

1. Pulmonary embolism
2. Collaborative study of cardiovascular disease and steroid hormone contraception. Venous thromboembolic disease and combined oral contraceptives: Results of international multicentre case-control study
3. Enhancement by factor V Leiden mutation of risk of deep-vein-thrombosis associated with oral contraceptives containing a third-generation progestagen
4. Venous thrombosis: A multicausal disease
5. Effect of oral contraceptives on haemostasis variables
6. Effects of progestogens on haemostasis
7. Collaborative study of cardiovascular disease and steroid hormone contraception. Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease
8. Third generation oral contraceptives and risk of venous thromboembolic disorders: An international case-control study
9. Risk of idiopathic cardiovascular death and non-fatal thromboembolism in women using oral contraceptives with differing progestogen components
10. The increased risk of venous thromboembolism and the use of third generation progestagens: Role of bias in observational research
11. Population-based study of risk of venous thromboembolism associated with various oral contraceptives
12. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis
13. Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: A cross-over study
14. A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways
15. A multicentre study of coagulation and haemostatic variables during oral contraception: Variations with geographical location and ethnicity
16. Venous thrombosis, oral contraceptives, and high factor VIII levels
17. Comparative studies of 30 μg ethinyl estradiol combined with gestodene and desogestrel on blood coagulation, fibrinolysis, and platelets
18. Low-dose oral contraceptives and acquired resistance to activated protein C: A randomised cross-over study